SEC ownership of Cardlytics, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001666071.

Comparable stake leader

CAS Investment Partners, LLC

Disclosed value leader

CAS Investment Partners, LLC

Comparable rows

50/50

Latest evidence

20 May 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 2 signals
Latest 13D/G holder
CAS Investment Partners, LLC
Latest parsed ownership date
20 May 2026
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001666071
Issuer location
Atlanta, GA

Ownership snapshot

Top shareholders of Cardlytics, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
CAS Investment Partners, LLC
Disclosed value leader
CAS Investment Partners, LLC
Comparable rows
50/50
Latest evidence
20 May 2026
13D/G 13F 3/4/5 Lead comparable stake: 9.8% 13D/G row: CAS Investment Partners, LLC Showing 1-8 of 50 holder rows.

Quick read

CAS Investment Partners, LLC leads the comparable SEC ownership view at 9.8%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens CAS Investment Partners, LLC's linked filing trail.
Comparable ownership Top 5
CAS Investment Partners, LLC 9.8%
VANGUARD GROUP INC 4.6%
BlackRock, Inc. 2.1%
John L. Klinck Jr. 0.17%
Andre J. Fernandez 0.05%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
CAS Investment Partners, LLC
13D/G 13F
Company
9.8%
$10,656,037
5,198,067 shares
-$854,463 19 Aug 2025
VANGUARD GROUP INC
13D/G
The Vanguard Group
4.6%
$3,975,815
2,416,909 shares
$0 30 Jun 2025
BlackRock, Inc.
13D/G 13F
Company
2.1%
$1,810,565
1,098,977 shares
$0 30 Jun 2025
John L. Klinck Jr.
3/4/5
Director
0.17%
$192,918
89,593 shares
mixed-class rows
20 May 2026
Andre J. Fernandez
3/4/5
Director
0.05%
$27,625
26,310 shares
20 May 2026
Jonathan Edward Francis
3/4/5
Director
0.05%
$27,625
26,310 shares
20 May 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
3.9%
$2,166,535
2,063,367 shares
31 Mar 2026
683 Capital Management, LLC
13F
Company
13F
2.7%
$1,522,500
1,450,000 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$948,487.

Buys
$129,000
Insiders: 1
Sells
$1,077,487
Insiders: 4
Net
-$948,487
Shares: -749,481
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 200,000 Shares: 949,481
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 200,000 226,903 $129,000 $241,211 -$112,211
3-6 0 117,875 $0 $112,946 -$112,946
6-9 0 22,390 $0 $50,848 -$50,848
9-12 0 582,313 $0 $672,483 -$672,483

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 24 reporting-owner rows connected to Cardlytics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
24
Largest Forms 3/4/5 holder
Karim Saad Temsamani
Net 12M change
-$948,487
Latest report
20 May 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Karim Saad Temsamani Chief Executive Officer, Director $10,136,558 Mixed 01 Jun 2024
Alex Mishurov Director $8,262,768 Mixed 19 Sep 2023
Clifford Sosin 10%+ Owner $8,254,396 -$452,760 -5.2% Mixed 18 Aug 2025
Lynne Marie Laube Director $2,001,811 Mixed 08 Nov 2022
Scott D. Grimes Director $1,841,837 Mixed 08 Nov 2022
Amit Gupta Chief Executive Officer, Director $1,275,689 -$480,159 -27% Mixed 06 Apr 2026
Andrew Christiansen Chief Financial Officer $431,798 Mixed 18 Jul 2023
John Balen V Director $416,473 Mixed 23 May 2023
S. Aimee Lapic Director $385,598 Mixed 23 May 2024
Kirk L. Somers Chief Legal & Privacy Officer $348,668 Mixed 22 Jun 2022
Jessica Jensen Director $346,914 Mixed 23 May 2024
Alexis DeSieno Chief Financial Officer $339,017 -$74,114 -18% Mixed 01 Jan 2026
David Leslie Adams Director $247,176 Mixed 23 May 2023
Mark A. Johnson Director $229,611 Mixed 21 May 2022
David Thomas Evans Chief Financial Officer $201,249 +$129,000 +179% Filing P/S 15 May 2026
Nicholas Hollmeyer Lynton Chief Legal & Privacy Officer $198,650 -$70,454 -26% Mixed 01 Apr 2026
John L. Klinck Jr. Director $192,918 Mixed 20 May 2026
Liane Hornsey Director $133,838 Mixed 20 May 2026
Tony Weisman Director $100,923 Mixed 23 May 2023
Scott A. Hill Director $72,185 Median 20 May 2026

Recent insider transactions for Cardlytics, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Srishti A. Gupta CDLX Common Stock Options Exercise 178.9% 11,000 17,148 20 May 2026 Direct
Srishti A. Gupta CDLX Restricted Stock Units Options Exercise -100% -11,000 0 20 May 2026 Direct
Srishti A. Gupta CDLX Restricted Stock Unit Award 11,000 11,000 20 May 2026 Direct
Jonathan Edward Francis CDLX Common Stock Options Exercise 71.8% 11,000 26,310 20 May 2026 Direct
Jonathan Edward Francis CDLX Restricted Stock Units Options Exercise -100% -11,000 0 20 May 2026 Direct
Jonathan Edward Francis CDLX Restricted Stock Units Award 11,000 11,000 20 May 2026 Direct
Scott A. Hill CDLX Common Stock Options Exercise 19% 11,000 68,748 20 May 2026 Direct
Scott A. Hill CDLX Restricted Stock Units Options Exercise -100% -11,000 0 20 May 2026 Direct
Scott A. Hill CDLX Restricted Stock Unit Award 11,000 11,000 20 May 2026 Direct
Andre J. Fernandez CDLX Common Stock Options Exercise 71.8% 11,000 26,310 20 May 2026 Direct
Andre J. Fernandez CDLX Restricted Stock Units Options Exercise -100% -11,000 0 20 May 2026 Direct
Andre J. Fernandez CDLX Restricted Stock Units Award 11,000 11,000 20 May 2026 Direct
Liane Hornsey CDLX Common Stock Options Exercise 49.3% 11,000 33,326 20 May 2026 Direct
Liane Hornsey CDLX Restricted Stock Units Options Exercise -100% -11,000 0 20 May 2026 Direct
Liane Hornsey CDLX Restricted Stock Unit Award 11,000 11,000 20 May 2026 Direct
John L. Klinck Jr. CDLX Common Stock Options Exercise 14% 11,000 89,593 20 May 2026 Direct
John L. Klinck Jr. CDLX Restricted Stock Units Options Exercise -100% -11,000 0 20 May 2026 Direct
John L. Klinck Jr. CDLX Restricted Stock Units Award 11,000 11,000 20 May 2026 Direct
David Thomas Evans CDLX Common Stock Purchase 18.7% $31,650 $0.6330 50,000 317,930 18 May 2026 Direct
David Thomas Evans CDLX Common Stock Purchase 127.2% $97,350 $0.6490 150,000 267,930 15 May 2026 Direct
Amit Gupta CDLX Common Stock Sale -6.61% $82,892 $1.19 -69,833 987,387 06 Apr 2026 Direct
Amit Gupta CDLX Common Stock Sale -4.88% $56,502 $1.04 -54,225 1,057,220 02 Apr 2026 Direct
Amit Gupta CDLX Common Stock Sale -5.33% $61,924 $0.9900 -62,549 1,111,445 01 Apr 2026 Direct
Amit Gupta CDLX Common Stock Options Exercise 78% 514,350 1,173,994 01 Apr 2026 Direct
Amit Gupta CDLX Restricted Stock Units Options Exercise -100% -514,350 0 01 Apr 2026 Direct
Nicholas Hollmeyer Lynton CDLX Common Stock Sale -19.4% $39,893 $0.9900 -40,296 167,856 01 Apr 2026 Direct
Nicholas Hollmeyer Lynton CDLX Common Stock Options Exercise 69.4% 85,290 208,152 01 Apr 2026 Direct
Nicholas Hollmeyer Lynton CDLX Restricted Stock Units Options Exercise -100% -85,290 0 01 Apr 2026 Direct
Amit Gupta CDLX Restricted Stock Units Award 1,500,000 1,500,000 27 Feb 2026 Direct
Nicholas Hollmeyer Lynton CDLX Restricted Stock Unit Award 220,000 220,000 18 Feb 2026 Direct
Amit Gupta CDLX Common Stock Sale -6.41% $41,817 $0.9260 -45,159 659,644 18 Feb 2026 Direct
Amit Gupta CDLX Common Stock Sale -6.88% $46,948 $0.9020 -52,049 704,803 17 Feb 2026 Direct
Amit Gupta CDLX Common Stock Options Exercise 49.3% 250,000 756,852 16 Feb 2026 Direct
Amit Gupta CDLX Restricted Stock Units Options Exercise -66.7% -250,000 125,000 16 Feb 2026 Direct
David Thomas Evans CDLX Restricted Stock Units Award 1,000,000 1,000,000 12 Jan 2026 Direct
Nicholas Hollmeyer Lynton CDLX Common Stock Sale -4.84% $7,316 $1.17 -6,253 122,862 05 Jan 2026 Direct
Amit Gupta CDLX Common Stock Sale -1.13% $6,794 $1.17 -5,807 506,852 05 Jan 2026 Direct
Alexis DeSieno CDLX Common Stock Sale -4.1% $10,070 $1.17 -8,607 201,159 05 Jan 2026 Direct
Nicholas Hollmeyer Lynton CDLX Common Stock Options Exercise 11% 12,788 129,115 01 Jan 2026 Direct
Nicholas Hollmeyer Lynton CDLX Restricted Stock Units Options Exercise -33.3% -1,578 3,156 01 Jan 2026 Direct
Nicholas Hollmeyer Lynton CDLX Restricted Stock Unit Options Exercise -95.1% -11,210 582 01 Jan 2026 Direct
Amit Gupta CDLX Common Stock Options Exercise 2.88% 14,349 512,659 01 Jan 2026 Direct
Amit Gupta CDLX Restricted Stock Units Options Exercise -50% -14,349 14,350 01 Jan 2026 Direct
Alexis DeSieno CDLX Common Stock Options Exercise 7.34% 14,349 209,766 01 Jan 2026 Direct
Alexis DeSieno CDLX Restricted Stock Units Options Exercise -50% -14,349 14,350 01 Jan 2026 Direct
Srishti A. Gupta CDLX Common Stock Options Exercise 6,148 6,148 30 Oct 2025 Direct
Srishti A. Gupta CDLX Restricted Stock Unit Options Exercise -100% -6,148 0 30 Oct 2025 Direct
Nicholas Hollmeyer Lynton CDLX Common Stock Sale -4.98% $13,849 $2.27 -6,098 116,327 02 Oct 2025 Direct
Amit Gupta CDLX Common Stock Sale -1.54% $17,712 $2.27 -7,799 498,310 02 Oct 2025 Direct
Alexis DeSieno CDLX Common Stock Sale -4.17% $19,288 $2.27 -8,493 195,417 02 Oct 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .